BR9608746A - Linhagem de célula produzindo compostos analgésicos para tratamento da dor - Google Patents

Linhagem de célula produzindo compostos analgésicos para tratamento da dor

Info

Publication number
BR9608746A
BR9608746A BR9608746A BR9608746A BR9608746A BR 9608746 A BR9608746 A BR 9608746A BR 9608746 A BR9608746 A BR 9608746A BR 9608746 A BR9608746 A BR 9608746A BR 9608746 A BR9608746 A BR 9608746A
Authority
BR
Brazil
Prior art keywords
cell line
pain management
line producing
analgesic compounds
producing analgesic
Prior art date
Application number
BR9608746A
Other languages
English (en)
Portuguese (pt)
Inventor
Joel Saydoff
Shou Wong
Original Assignee
Cytotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytotherapeutics Inc filed Critical Cytotherapeutics Inc
Publication of BR9608746A publication Critical patent/BR9608746A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9608746A 1995-06-07 1996-06-07 Linhagem de célula produzindo compostos analgésicos para tratamento da dor BR9608746A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
PCT/US1996/009629 WO1996040959A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Publications (1)

Publication Number Publication Date
BR9608746A true BR9608746A (pt) 1999-05-11

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608746A BR9608746A (pt) 1995-06-07 1996-06-07 Linhagem de célula produzindo compostos analgésicos para tratamento da dor

Country Status (20)

Country Link
EP (1) EP0833935A1 (en:Method)
JP (1) JPH11507530A (en:Method)
KR (1) KR19990022414A (en:Method)
CN (1) CN1192246A (en:Method)
AR (1) AR004494A1 (en:Method)
AU (1) AU6263696A (en:Method)
BR (1) BR9608746A (en:Method)
CA (1) CA2223246A1 (en:Method)
CZ (1) CZ392497A3 (en:Method)
EE (1) EE9700326A (en:Method)
HU (1) HUP9901191A2 (en:Method)
IL (1) IL122415A0 (en:Method)
IN (1) IN181898B (en:Method)
IS (1) IS4628A (en:Method)
NO (1) NO975545L (en:Method)
PL (1) PL323867A1 (en:Method)
SK (1) SK167997A3 (en:Method)
TR (1) TR199701520T1 (en:Method)
WO (1) WO1996040959A1 (en:Method)
ZA (1) ZA964880B (en:Method)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034257A2 (en) * 1997-11-28 2000-09-13 Medical Research Council Yac vectors
WO2000016799A1 (en) 1998-09-23 2000-03-30 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of treating chronic pain
WO2000024895A2 (en) * 1998-10-27 2000-05-04 Anticancer, Inc. Method and model for hair pigmentation
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
NZ547767A (en) 2003-12-24 2010-05-28 Inst Medical W & E Hall Therapeutic agents and uses therefor
WO2005108981A1 (en) 2004-05-12 2005-11-17 The Walter And Eliza Hall Institute Of Medical Research A method of cell isolation
DK2407484T3 (en) 2005-06-24 2016-09-05 The Walter And Eliza Hall Inst Of Medical Res Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those
AU2007275764B2 (en) 2006-07-18 2013-11-14 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
CN105377286B (zh) 2013-05-31 2021-07-02 犹他大学研究基金会 芋螺毒素(conotoxin)肽，其医药组合物和用途
CA3003294A1 (en) 2015-10-27 2017-05-04 The University Of Queensland Modified epha4 and uses thereof
CN107964047B (zh) * 2017-12-18 2018-11-02 哈尔滨工业大学 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) * 2021-03-26 2021-06-04 河北医科大学 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005452A2 (en) * 1993-08-12 1995-02-23 Cytotherapeutics, Inc. Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules

Also Published As

Publication number Publication date
ZA964880B (en) 1997-01-07
CZ392497A3 (cs) 1998-12-16
WO1996040959A1 (en) 1996-12-19
AR004494A1 (es) 1998-12-16
NO975545D0 (no) 1997-12-02
CN1192246A (zh) 1998-09-02
NO975545L (no) 1998-02-04
CA2223246A1 (en) 1996-12-19
IS4628A (is) 1997-12-04
HUP9901191A2 (hu) 1999-08-30
AU6263696A (en) 1996-12-30
PL323867A1 (en) 1998-04-27
JPH11507530A (ja) 1999-07-06
TR199701520T1 (xx) 1998-04-21
IN181898B (en:Method) 1998-10-24
IL122415A0 (en) 1998-06-15
EP0833935A1 (en) 1998-04-08
KR19990022414A (ko) 1999-03-25
SK167997A3 (en) 1998-05-06
EE9700326A (et) 1998-06-15

Similar Documents

Publication Publication Date Title
EE9800194A (et) Uued valuvaigistava toimega ühendid
FI970101A7 (fi) Uusi farmaseuttinen valmiste kivun hallintaan
BR9509985A (pt) Solução para irrigação e método para inibição de dor inflamação e esparmo
BR9608746A (pt) Linhagem de célula produzindo compostos analgésicos para tratamento da dor
BR9608956A (pt) Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto
DE69623222D1 (de) Ereignisverwaltungssystem
BR9707373A (pt) Consolador para distribuição de medicamento
DE69624501D1 (de) Personenbezogenes zugangsverwaltungssystem
DE69718166D1 (de) Trägerbahnlose chirurgische einschneidabdeckungsrolle
PT946510E (pt) Novos compostos com efeito analgesico
BR9608908A (pt) Composto composição farmacêutica processos para aliviar dor e para preparar um composto
BR9610817A (pt) Comprimidos mastigáveis
BR9610836A (pt) Composição antibacterial para administração oral
DK0674895T3 (da) Smertebehandlingsapparat
BR9610214A (pt) Compostos farmacéuticos
DE69615831D1 (de) Speicherverwaltung
PT1089965E (pt) Derivados de ureia para tratamento da dor
IL124997A0 (en) Compounds with analgesic effect
BR9510162A (pt) Medicamento para influenciar afecções da formação óssea
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
NO965448D0 (no) Farmasöytiske forbindelser
EP0776666A3 (en) Analgesic and anti-inflammatory medication
BR9612730A (pt) Derivado de clonixin analg-sico/antinflamatÄrio nÆo-ulcerog-nico
ES1034872Y (es) Aplicador para medicamentos.
DE59604427D1 (de) Speicherverwaltungsverfahren

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law